ライフサイエンスコーパス: respiratory disease

1 of having COPD, including 152 deaths due to respiratory disease.

2 nge values derived from a population without respiratory disease.

3 ay a key role in determining the severity of respiratory disease.

4 auses isolated cases and outbreaks of severe respiratory disease.

5 iratory tract symptom of aspirin-exacerbated respiratory disease.

6 hlessness is the most threatening symptom of respiratory disease.

7 nd in doing so, predispose animals to bovine respiratory disease.

8 V-have crossed species to cause severe human respiratory disease.

9 ory pharmacotherapeutic approaches to combat respiratory disease.

10 y related avian coronaviruses like IBV cause respiratory disease.

11 recipients and may be associated with severe respiratory disease.

12 irus (RSV) is the leading cause of pediatric respiratory disease.

13 sociated with an outbreak of enterovirus-D68 respiratory disease.

14 ry syncytial virus (RSV), a leading cause of respiratory disease.

15 may provide potential therapies for chronic respiratory disease.

16 ng vaccinated dogs showing clinical signs of respiratory disease.

17 wine populations and plays multiple roles in respiratory disease.

18 human pathogens, some of which cause severe respiratory disease.

19 gerated in patients with aspirin-exacerbated respiratory disease.

20 in military boot camps and civilian cases of respiratory disease.

21 ed on a set of 208 samples from bovines with respiratory disease.

22 nst canine distemper virus (CDV) and develop respiratory disease.

23 V circulates seasonally, causing acute lower respiratory disease.

24 causing sporadic severe and frequently fatal respiratory disease.

25 wine populations and plays multiple roles in respiratory disease.

26 or susceptible conditions for development of respiratory disease.

27 1-72 years who were free of cancer, CVD, and respiratory disease.

28 eatment of ILC2-mediated allergic asthma and respiratory disease.

29 reased susceptibility to viral-induced upper respiratory disease.

30 al exposure is an important, global cause of respiratory disease.

31 ive treatment option for aspirin-exacerbated respiratory disease.

32 of allergic disease, in particular allergic respiratory disease.

33 and at distances greater than 7 km for fatal respiratory disease.

34 ble to all patients with aspirin-exacerbated respiratory disease.

35 tagonists for concomitant cardiovascular and respiratory disease.

36 surfactant that works in an animal model of respiratory disease.

37 the risk of asthma in offspring and allergic respiratory disease.

38 re and might predispose to certain postnatal respiratory diseases.

39 genetic mechanisms in patients with allergic respiratory diseases.

40 ot detected in humans diagnosed with chronic respiratory diseases.

41 air pollutants and their impacts on chronic respiratory diseases.

42 siologic states, including acute and chronic respiratory diseases.

43 ions in the ELF to levels characteristic for respiratory diseases.

44 is a common cause of bacterial infections in respiratory diseases.

45 ns of genetic overlap between COPD and other respiratory diseases.

46 an 5% of all NIH-funded published studies of respiratory diseases.

47 hose encoding proteins implicated in chronic respiratory diseases.

48 sputum is a valuable matrix in the study of respiratory diseases.

49 essing pulmonary dysfunction in a variety of respiratory diseases.

50 ecognized risk factor for cardiovascular and respiratory diseases.

51 ith cystic fibrosis as well as other chronic respiratory diseases.

52 a in both healthy subjects and patients with respiratory diseases.

53 the role of the microbiota in patients with respiratory diseases.

54 an important animal model for multiple human respiratory diseases.

55 dized mortality rates by county from chronic respiratory diseases.

56 ) was developed for the inhaled treatment of respiratory diseases.

57 ortality rates from 1980 to 2014 for chronic respiratory diseases.

58 sissippi to South Carolina for other chronic respiratory diseases.

59 ertension (3,227), diabetes (1,842), chronic respiratory disease (1,157) or who screened positive for

60 , RR 1.10 [0.97 to 1.24; p = 0.126]; chronic respiratory disease: 14% versus 12%, RR 1.08 [0.75 to 1.

61 -suicide unnatural causes (4.01, 3.34-4.78), respiratory disease (3.38, 3.04-3.74), cardiovascular di

62 ular diseases, cancer, diabetes, and chronic respiratory diseases, 4 leading causes of mortality.

63 es were infectious diseases (7.8%-15.1%) and respiratory diseases (6.0%-7.6%; P<0.001 for both), wher

64 older), malignant neoplasms (15.1%), chronic respiratory diseases (9.5%), musculoskeletal diseases (7

65 Aspirin-exacerbated respiratory disease, a severe asthma subtype, is charact

66 e the utility of the methodology in studying respiratory diseases, a comparative lipid screening was

67 The virus causes respiratory disease, abortion, and, in some cases, neuro

68 erculosis, malaria and other infections, and respiratory diseases accounted for about 60% of the abso

69 Aspirin-exacerbated respiratory disease (AERD) is a chronic inflammatory dis

70 Aspirin-exacerbated respiratory disease (AERD) is characterized by 3 clinica

71 Aspirin-exacerbated respiratory disease (AERD) is characterized by tissue eo

72 Aspirin-exacerbated respiratory disease (AERD) is manifested by adult-onset

73 Aspirin-exacerbated respiratory disease (AERD), a severe eosinophilic inflam

74 eases, including asthma, aspirin-exacerbated respiratory disease (AERD), inflammatory bowel disease,

75 reported alterations in aspirin-exacerbated respiratory disease (AERD), reduced expression/productio

76 actions in patients with aspirin-exacerbated respiratory disease (AERD).

77 formed for patients with aspirin-exacerbated respiratory disease (AERD).

78 sal polyps (CRSwNP), and aspirin-exacerbated respiratory disease (AERD).

79 tial virus (RSV) is a common cause of severe respiratory disease among infants, immunocompromised ind

80 hospitalizations for both cardiovascular and respiratory disease among Medicare enrollees >/= 65 year

81 July 2007 for England) and the incidence of respiratory diseases among children.

82 dant that contributes to the exacerbation of respiratory disease and can function as an adjuvant to a

83 ment in Primary Care to Identify Undiagnosed Respiratory Disease and Exacerbation Risk), was used to

84 1 and H7N9, have been associated with severe respiratory disease and fatal outcomes in humans.

85 nza viruses have been associated with severe respiratory disease and fatal outcomes in humans.

86 rus (RSV) infections remain a major cause of respiratory disease and hospitalizations among infants.

87 ed and altered disease course with decreased respiratory disease and increased terminal neurological

88 IL-17A plays an important role in respiratory disease and is a known regulator of pulmonar

89 s an emerging pathogen that can cause severe respiratory disease and is associated with cases of para

90 er less than or equal to 2.5 mum (PM2.5)) on respiratory disease and lung cancer mortality is poorly

91 ) is an important viral pathogen that causes respiratory disease and suppresses immune responses in c

92 s suggest that IDV is common in bovines with respiratory disease and that at least two genetic and an

93 ever, dramatically decreased the severity of respiratory disease and the level of destruction of sple

94 and clinical manifestations associated with respiratory disease and to identify potential diagnostic

95 ruption of ciliary motion can lead to severe respiratory diseases and compromised respiratory functio

96 otic viruses that can cause severe and acute respiratory diseases and encephalitis in humans.

97 8 (EV-D68) is a causative agent of childhood respiratory diseases and has now emerged as a global pub

98 In models of allergic respiratory diseases and in vitro studies, direct Ag eng

99 re responsible for the majority of pediatric respiratory diseases and inflict significant economic lo

100 echanism for how infections could exacerbate respiratory diseases and may highlight a possible signal

101 important part of the management of allergic respiratory diseases and requires standardized allergen

102 n, tuberculosis infection, diabetes, chronic respiratory disease, and blindness health programmes; pr

103 e (stroke and heart attack), cancer, chronic respiratory disease, and diabetes are a leading cause of

104 th, including cancer, heart disease, stroke, respiratory disease, and infection.

105 tacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS

106 nic and ischemic heart disease, nonmalignant respiratory disease, and lung, skin, bladder, and kidney

107 a, and its failure results in brain defects, respiratory diseases, and infertility.

108 rynx, or intrathoracic organs; other cancer; respiratory disease; and cardiovascular disease.

109 re highly contagious pathogens causing acute respiratory disease (ARD), such as community-acquired pn

110 d alternative medicine by women to influence respiratory disease are examined, and future directions

111 Chronic respiratory diseases are among the leading causes of dea

112 Chronic respiratory diseases are an important cause of death and

113 Non-communicable respiratory diseases are an increasing problem at both e

114 Understanding whether respiratory diseases are associated with dysfunction of

115 Respiratory diseases are highly complex, being driven by

116 Ozone has been associated with respiratory diseases as well as cardiovascular morbidity

117 impairment establishes clinically meaningful respiratory disease, as validated by graded associations

118 ronchopulmonary dysplasia (BPD) is a chronic respiratory disease associated with premature birth that

119 sociated CV-A16 and CV-A6, as well as severe respiratory disease-associated EV-D68, have developed a

120 sociated CV-A16 and CV-A6, as well as severe respiratory disease-associated EV-D68, have developed no

121 rovide tools to understand the mechanisms of respiratory diseases at the single-cell level.

122 Bovine respiratory disease (BRD) is a common health problem for

123 Bovine respiratory disease (BRD) is the most common infectious

124 BHV-1 is a major viral pathogen of Bovine Respiratory Disease (BRD), the leading cause of economic

125 pendently decreased the severity of clinical respiratory disease but did not decrease lethality.

126 o be critical for the development of chronic respiratory disease, but the link between these events n

127 are involved in the pathophysiology of many respiratory diseases, but the exact role of eosinophilia

128 erse health effects such as asthma and other respiratory diseases, but the underlying chemical proces

129 olyps of 3 patients with aspirin-exacerbated respiratory disease by using fluorescence-activated cell

130 exposure (the putative bacterial agent of a respiratory disease) by varying the duration of interact

131 ons, so that dysregulations in patients with respiratory diseases can be detected to elucidate their

132 rom the lowest socioeconomic group and fatal respiratory disease cases aged >/=60 y were underreprese

133 ease cases and 18% (95% CI 16%-21%) of fatal respiratory disease cases residing at 10 km distance fro

134 spiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel single-stranded, p

135 n in the hypertension, diabetes, and chronic respiratory disease cohorts, defined as the proportion o

136 IDV is common in clinical samples of bovine respiratory disease complex (BRDC), with a prevalence si

137 r of pathogens that contribute to the bovine respiratory disease complex (BRDC).

138 major bovine pathogen associated with bovine respiratory disease complex and is responsible for subst

139 icum, the primary etiologic agent of chronic respiratory disease (CRD) in poultry, leads to prolonged

140 may eventually lead to tissue remodeling and respiratory disease.Cystic fibrosis is caused by mutatio

141 erved for deaths from heart disease, chronic respiratory diseases, diabetes, pneumonia and influenza,

142 Analysis by qPCR of 271 porcine respiratory disease diagnostic submission samples identi

143 to maternal smoking had higher rates of late respiratory disease during childhood.

144 isk for bronchopulmonary dysplasia (BPD) and respiratory disease during early childhood after preterm

145 ts without BPD had no clinical signs of late respiratory disease during early childhood.

146 nd some evidence of positive associations of respiratory disease ED visits with biomass burning PM2.5

147 sociations between source-specific PM2.5 and respiratory disease ED visits.

148 sociations between source-specific PM2.5 and respiratory disease emergency department (ED) visits and

149 tory hurdles resulting from vaccine enhanced respiratory disease (ERD) subsequent to natural RSV infe

150 ne has been associated with serious enhanced respiratory disease (ERD).

151 Many measures of chronic diseases, including respiratory disease, exhibit seasonal variation together

152 ten severe infection that regularly involves respiratory disease following inhalation exposure.

153 eumovirus (HMPV) is a leading cause of acute respiratory disease for which there is no licensed vacci

154 sociation was more pronounced for death from respiratory diseases (for napping less than 1 hour, haza

155 NERGY project pooled information on previous respiratory diseases from 12,739 case subjects and 14,94

156 al regions and reduce the burden of allergic respiratory disease globally.

157 apy, the aetiological treatment for allergic respiratory diseases, has demonstrated to be an effectiv

158 Yet very few new, effective therapies for respiratory disease have been approved for use.

159 Models of MERS-CoV-induced severe respiratory disease have been difficult to achieve, and

160 g the principles of respiratory mechanics to respiratory disease have used inconsistent and mutually

161 coronavirus (MERS-CoV) as a cause of severe respiratory disease highlights the need for effective ap

162 nfluenza A viruses cause annual epidemics of respiratory disease; highly pathogenic avian H5N1 and th

163 both C and W expression resulted in limited respiratory disease; however, there was severe neurologi

164 cancer (HR = 0.84, 95% CI: 0.77, 0.92), and respiratory disease (HR = 0.71, 95% CI: 0.63, 0.80) but

165 disease (HR = 1.08, 95% CI: 1.00, 1.16), and respiratory disease (HR = 1.20, 95% CI: 1.14, 1.26).

166 er (HR, 14.48; 95% CI, 9.89 to 21.21), other respiratory disease (HR, 6.02; 95% CI, 4.55 to 7.97), an

167 The effects of smoking on the risk of respiratory diseases, hypertension and myocardial infarc

168 itively associated with the risk of incident respiratory diseases, hypertension and myocardial infarc

169 tudy was to examine the impact of smoking on respiratory diseases, hypertension and myocardial infarc

170 und between smoking and the risk of incident respiratory diseases, hypertension and myocardial infarc

171 nderlying comorbidities, such as cardiac and respiratory disease, immunosuppression, and pregnancy.

172 renia, excess deaths from cardiovascular and respiratory diseases implicate modifiable cardiovascular

173 atory syncytial virus (RSV) can cause severe respiratory disease in adult hematopoietic cell transpla

174 us (HMPV) causes significant upper and lower respiratory disease in all age groups worldwide.

175 the specific mortality of cardiovascular and respiratory disease in Beijing was initially projected u

176 these processes may contribute to worsening respiratory disease in CFRD.

177 Paramyxoviridae family and a major cause of respiratory disease in children.

178 8) occurred in North America, causing severe respiratory disease in children.

179 ive agents of canine influenza, a contagious respiratory disease in dogs, and include the equine-orig

180 e matter and emergency department visits for respiratory disease in four U.S. cities.

181 sponsible for rapidly spreading outbreaks of respiratory disease in horses.

182 ratory pathogen causing both upper and lower respiratory disease in humans of all ages, and it can al

183 ive agent of febrile encephalitis and severe respiratory disease in humans.

184 hogens that, upon infection, can cause fatal respiratory disease in humans.

185 s one of the major causative agents of acute respiratory disease in humans.

186 0% of the world population and causes severe respiratory disease in infants, the elderly, and immunoc

187 n metapneumovirus (HMPV) is a major cause of respiratory disease in infants, the elderly, and immunoc

188 Human RSV is an important cause of respiratory disease in infants, the elderly, and the imm

189 utcomes of include abortion, fetal death and respiratory disease in newborn piglets.

190 revention reported over 1000 cases of severe respiratory disease in pediatric patients associated wit

191 bally for more than 60 years, causing severe respiratory disease in pediatric, elderly, and immunocom

192 fluenza A viruses (IAV) are a major cause of respiratory disease in pigs and humans.

193 um is the primary etiologic agent of chronic respiratory disease in poultry, a disease largely affect

194 fection(s) represent a substantial burden of respiratory disease in the US outpatient setting, partic

195 se is required for control of virus-mediated respiratory disease in young children.

196 accidental causes, cardiovascular (CVD), and respiratory diseases in 517,041 men and women enrolled i

197 of whooping cough in humans and a variety of respiratory diseases in animals, respectively.

198 increase (1.2%-267%) in hospitalisations for respiratory diseases in children under-five in municipal

199 ten subclinical infection on the severity of respiratory diseases in early infancy.

200 mal diseases, including both mild and severe respiratory diseases in humans.

201 iolitis is one of the most common and costly respiratory diseases in infants and young children.

202 order Nidovirales PRRSV is a major agent of respiratory diseases in pigs, causing tremendous economi

203 Occupational respiratory diseases in workers of peach tree crops have

204 n the context of diagnosis and monitoring of respiratory diseases including asthma, chronic obstructi

205 y microbiota are associated with progressive respiratory diseases including chronic obstructive pulmo

206 artment visits (EDVs) for cardiovascular and respiratory diseases, including 7 subclasses.

207 Human bocavirus 1 infection causes respiratory diseases, including acute wheezing in infant

208 are critical processes in the development of respiratory diseases, including asthma.

209 unction is critical in the pathology of many respiratory diseases, including cystic fibrosis.

210 critical role in the pathogenesis of several respiratory diseases, including cystic fibrosis.

211 There is evidence that patients with respiratory diseases, including severe asthma (SA), disp

212 Nationally, the mortality rate from chronic respiratory diseases increased from 40.8 (95% uncertaint

213 ew genetic and pharmaceutical treatments for respiratory diseases into clinical trials.

214 ovided a guideline for MSI investigations of respiratory diseases involving the airways, including th

215 Aspirin-exacerbated respiratory disease is a severe form of chronic rhinosin

216 pulmonary eosinophilia linked with allergic respiratory disease is able to promote antiviral host de

217 Bovine respiratory disease is the most economically important d

218 the mainstay of anti-inflammatory therapy in respiratory diseases is corticosteroids.

219 Millions of people are affected by respiratory diseases, leading to a significant health bu

220 ramyxoviruses include global causes of lower respiratory disease like the parainfluenza viruses, as w

221 ulted in 100% mortality, though with limited respiratory disease, like our previously reported rNiV v

222 ymphoid cells (ILC2s) in aspirin-exacerbated respiratory disease-like Ptges(-/-) mice.

223 tal processes and their relation to neonatal respiratory diseases, little is understood about the mol

224 vegetarians (HR: 0.50; 95% CI: 0.32, 0.79)]; respiratory disease [lower in low meat eaters (HR: 0.70;

225 ficantly related to increased mortality from respiratory disease, lung cancer, and cardiovascular dis

226 The presence of respiratory disease may affect tissue oxygenation and en

227 , heart diseases (men: 1.2; women: 0.3), and respiratory diseases (men: 0.3; women: 0.2), and a decre

228 in terms of excess life-years lost were for respiratory diseases (men: 0.9; women: 1.4) and alcohol

229 rt-term effects of air pollution exposure on respiratory disease mortality are well established.

230 te recent declines in mortality from chronic respiratory diseases, mortality rates in 2014 remained s

231 d the relationship between NSAID-exacerbated respiratory disease (NERD) and asthma morbidity was less

232 RATIONALE: Despite the high burden of respiratory disease, no spirometry reference values for

233 olyps from patients with aspirin-exacerbated respiratory disease (NP-AERD, n = 8).

234 nd bronchiolitis obliterans and other severe respiratory diseases observed in workers, urgent action

235 ratio, 2.78; 95% CI, 1.40-5.51), and chronic respiratory disease (odds ratio, 1.85; 95% CI, 1.03-3.3)

236 s bovine pleuropneumonia (CBPP) is a serious respiratory disease of cattle caused by Mycoplasma mycoi

237 racheitis (ILT) is a highly contagious acute respiratory disease of chickens caused by infectious lar

238 Canine influenza is a respiratory disease of dogs caused by canine influenza v

239 in mammals.IMPORTANCE Canine influenza is a respiratory disease of dogs caused by two CIV subtypes,

240 5% CI, 1.10-2.67), have a history of chronic respiratory disease (OR, 1.61; 95% CI, 1.17-2.22), and w

241 all causes, coronary heart disease, stroke, respiratory disease, or cancer in any of our analyses.

242 elf-rated health, cancer, heart disease, and respiratory disease (ORs of two to three), strong for se

243 ifunctional prostanoid with diverse roles in respiratory disease, our studies demonstrate a novel fun

244 This respiratory disease outbreak was due to multiple pathoge

245 mpanzee communities in the course of several respiratory disease outbreaks.

246 IOPRED (Unbiased Biomarkers in Prediction of Respiratory Disease Outcomes) study.

247 an Unbiased Biomarkers for the Prediction of Respiratory Diseases Outcomes (U-BIOPRED) adult cohort u

248 to pre-existing trends, while mortality from respiratory diseases (p = 0.053) and transport accidents

249 able target for anti-inflammatory therapy in respiratory diseases, particularly in the management of

250 ypes will better refine our understanding of respiratory disease pathogenesis and lead to new diagnos

251 f pro-inflammatory cytokines responsible for respiratory disease pathogenesis.

252 Yersinia pestis causes the fatal respiratory disease pneumonic plague.

253 eases in deaths classified as resulting from respiratory disease (posterior probability of positive a

254 A high proportion of cornea donors have respiratory disease prior to donation.

255 ngeal flora, contributing to the severity of respiratory disease progression.

256 ematological disorders in the Africa region; respiratory disease, psychiatric disorders, renal disord

257 oup at 6 and 12 months, based on the Chronic Respiratory Disease Questionnaire emotional score (emoti

258 08]; adjusted HR, 1.26 [95% CI, 1.04-1.53]), respiratory disease (rate difference, 0.02 per 1000 pers

259 tive risk, 2.3; 95% CI, 2.0 to 2.7), various respiratory diseases (relative risk, 2.0; 95% CI, 1.6 to

260 RSV is the leading cause of childhood acute respiratory disease requiring hospitalization.

261 -2 OP(DTT) was associated with ED visits for respiratory disease (RR=1.03, 95% confidence interval (C

262 protein levels were investigated in another respiratory disease, sarcoidosis, showing significantly

263 ved for deaths due to heart disease, cancer, respiratory disease, stroke, diabetes, and kidney diseas

264 licate the airway microbiome in inflammatory respiratory diseases such as asthma and COPD.

265 Respiratory diseases such as asthma, chronic obstructive

266 nity, which may have adverse consequences in respiratory diseases such as COPD.

267 rd of hospitalizations due to COPD and other respiratory diseases than did those without.

268 Influenza is an acute viral respiratory disease that affects persons of all ages and

269 Influenza A virus triggers a contagious respiratory disease that can cause considerable morbidit

270 Necessary factors include a source case with respiratory disease that has developed sufficiently for

271 Atopic asthma is a prevalent respiratory disease that is characterized by inflammatio

272 m, with influenza virus causing a contagious respiratory disease that is most effectively prevented t

273 ite the consistent clinical phenotype of the respiratory disease, the underlying pathogenesis of the

274 s and heart resulting in cardio-vascular and respiratory disease through the production of reactive o

275 t lead to the development and progression of respiratory diseases, treatment options remain limited.

276 ality by county, sex, and particular chronic respiratory disease type.

277 hospitalized with an exacerbation of chronic respiratory disease underwent measures of muscle functio

278 is study demonstrates that IDV causes a mild respiratory disease upon experimental infection of cattl

279 A 47-year-old woman with aspirin-exacerbated respiratory disease visited our hospital complaining of

280 We also observed a robust association of respiratory disease visits with ozone.

281 oma City that were showing clinical signs of respiratory disease were evaluated for CDV antigen using

282 n counties, and mortality rates from chronic respiratory disease were highest in counties in eastern

283 comes after standard symptomatic therapy for respiratory disease were recorded, and a statistical ana

284 diovascular diseases, suicide, infection and respiratory diseases were 1.29 (95% CI 1.20 to 1.38), 2.

285 al admissions focusing on cardiovascular and respiratory diseases were obtained for Augsburg and Dres

286 A total of 4616711 deaths due to chronic respiratory diseases were recorded in the United States

287 idomycosis is a potentially life-threatening respiratory disease which is endemic to the southwestern

288 m, with influenza virus causing a contagious respiratory disease which is most effectively prevented

289 against others of the same subtype or common respiratory diseases while still exhibiting fast binding

290 unique challenges for patients with chronic respiratory disease who might need access to several typ

291 data were collected from 63 subjects without respiratory diseases who underwent spirometry and MostGr

292 d in 2012 as the causative agent of a severe respiratory disease with a fatality rate of approximatel

293 ory syndrome coronavirus (SARS-CoV) causes a respiratory disease with a mortality rate of 10%.

294 MERS-CoV causes a severe respiratory disease with high fatality rates in human pa

295 s (for diabetes, cardiovascular disease, and respiratory disease) with overall health gains of 420-82

296 ovirus (HMPV) is a paramyxovirus that causes respiratory disease worldwide.

297 ond leading viral causes of severe pediatric respiratory disease worldwide.

298 foot, and mouth disease (HFMD) and pediatric respiratory disease worldwide.

299 hand, foot, and mouth disease and pediatric respiratory disease worldwide.

300 economic benefits for patients with chronic respiratory diseases, yet it is underutilized worldwide.